These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15713679)

  • 1. Biochemical and enzymatic characterization of human kallikrein 5 (hK5), a novel serine protease potentially involved in cancer progression.
    Michael IP; Sotiropoulou G; Pampalakis G; Magklara A; Ghosh M; Wasney G; Diamandis EP
    J Biol Chem; 2005 Apr; 280(15):14628-35. PubMed ID: 15713679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human kallikrein protein 5 (hK5) is enzymatically active, glycosylated and forms complexes with two protease inhibitors in ovarian cancer fluids.
    Yousef GM; Kapadia C; Polymeris ME; Borgono C; Hutchinson S; Wasney GA; Soosaipillai A; Diamandis EP
    Biochim Biophys Acta; 2003 Jul; 1628(2):88-96. PubMed ID: 12890555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and functional characterization of the cancer-related serine protease, human tissue kallikrein 14.
    Borgoño CA; Michael IP; Shaw JL; Luo LY; Ghosh MC; Soosaipillai A; Grass L; Katsaros D; Diamandis EP
    J Biol Chem; 2007 Jan; 282(4):2405-22. PubMed ID: 17110383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical characterization of human kallikrein 8 and its possible involvement in the degradation of extracellular matrix proteins.
    Rajapakse S; Ogiwara K; Takano N; Moriyama A; Takahashi T
    FEBS Lett; 2005 Dec; 579(30):6879-84. PubMed ID: 16337200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and enzymatic characterization of recombinant human kallikrein 14.
    Rajapakse S; Takahashi T
    Zoolog Sci; 2007 Aug; 24(8):774-80. PubMed ID: 18217483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human tissue kallikrein 5 is a member of a proteolytic cascade pathway involved in seminal clot liquefaction and potentially in prostate cancer progression.
    Michael IP; Pampalakis G; Mikolajczyk SD; Malm J; Sotiropoulou G; Diamandis EP
    J Biol Chem; 2006 May; 281(18):12743-50. PubMed ID: 16517595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of the zinc inhibition of human tissue kallikrein 5.
    Debela M; Goettig P; Magdolen V; Huber R; Schechter NM; Bode W
    J Mol Biol; 2007 Nov; 373(4):1017-31. PubMed ID: 17881000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A proteolytic cascade of kallikreins in the stratum corneum.
    Brattsand M; Stefansson K; Lundh C; Haasum Y; Egelrud T
    J Invest Dermatol; 2005 Jan; 124(1):198-203. PubMed ID: 15654974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human kallikrein 4: enzymatic activity, inhibition, and degradation of extracellular matrix proteins.
    Obiezu CV; Michael IP; Levesque MA; Diamandis EP
    Biol Chem; 2006 Jun; 387(6):749-59. PubMed ID: 16800736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity and reactive loop length requirements for crmA inhibition of serine proteases.
    Tesch LD; Raghavendra MP; Bedsted-Faarvang T; Gettins PG; Olson ST
    Protein Sci; 2005 Feb; 14(2):533-42. PubMed ID: 15632287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer.
    Yousef GM; Polymeris ME; Grass L; Soosaipillai A; Chan PC; Scorilas A; Borgoño C; Harbeck N; Schmalfeldt B; Dorn J; Schmitt M; Diamandis EP
    Cancer Res; 2003 Jul; 63(14):3958-65. PubMed ID: 12873991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of recombinant human tissue kallikrein at 2.0 A resolution.
    Katz BA; Liu B; Barnes M; Springman EB
    Protein Sci; 1998 Apr; 7(4):875-85. PubMed ID: 9568894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging interest in the kallikrein gene family for understanding and diagnosing cancer.
    Sotiropoulou G; Rogakos V; Tsetsenis T; Pampalakis G; Zafiropoulos N; Simillides G; Yiotakis A; Diamandis EP
    Oncol Res; 2003; 13(6-10):381-91. PubMed ID: 12725528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and regulation by inhibitors.
    Magklara A; Mellati AA; Wasney GA; Little SP; Sotiropoulou G; Becker GW; Diamandis EP
    Biochem Biophys Res Commun; 2003 Aug; 307(4):948-55. PubMed ID: 12878203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7.
    Caubet C; Jonca N; Brattsand M; Guerrin M; Bernard D; Schmidt R; Egelrud T; Simon M; Serre G
    J Invest Dermatol; 2004 May; 122(5):1235-44. PubMed ID: 15140227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunofluorometric quantification of human kallikrein 5 expression in ovarian cancer cytosols and its association with unfavorable patient prognosis.
    Diamandis EP; Borgoño CA; Scorilas A; Yousef GM; Harbeck N; Dorn J; Schmalfeldt B; Schmitt M
    Tumour Biol; 2003; 24(6):299-309. PubMed ID: 15004490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human glandular kallikrein, hK2, shows arginine-restricted specificity and forms complexes with plasma protease inhibitors.
    Mikolajczyk SD; Millar LS; Kumar A; Saedi MS
    Prostate; 1998 Jan; 34(1):44-50. PubMed ID: 9428387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human kallikreins 5 and 7 by the serine protease inhibitor lympho-epithelial Kazal-type inhibitor (LEKTI).
    Schechter NM; Choi EJ; Wang ZM; Hanakawa Y; Stanley JR; Kang Y; Clayman GL; Jayakumar A
    Biol Chem; 2005 Nov; 386(11):1173-84. PubMed ID: 16307483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1.
    Kirchhofer D; Peek M; Li W; Stamos J; Eigenbrot C; Kadkhodayan S; Elliott JM; Corpuz RT; Lazarus RA; Moran P
    J Biol Chem; 2003 Sep; 278(38):36341-9. PubMed ID: 12815039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase.
    Takayama TK; McMullen BA; Nelson PS; Matsumura M; Fujikawa K
    Biochemistry; 2001 Dec; 40(50):15341-8. PubMed ID: 11735417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.